Особливості патогенезу порушень водно-сольового обміну у хворих на хронічну серцеву недостатність та обґрунтування шляхів їх корекції

Вдосконалення лікування хворих на хронічну серцеву недостатність (ХСН) на підставі вивчення механізмів водно-сольового обміну. Особливості порушень функціонального стану нирок у хворих на ХСН. Медикаментозна корекція порушень водно-сольового обміну.

Рубрика Медицина
Вид диссертация
Язык украинский
Дата добавления 25.06.2018
Размер файла 585,8 K

Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже

Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.

198. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade / V. Dzau // J. Hypertens. Suppl. - 2005. - Vol. 23 (1). - P. 9-17.

199. Effect of ultrafiltration versus intravenous furosemide for decompensated heart failure in cardiorenal syndrome: a systematic review with meta-analysis of randomized controlled trials / H. Y. Chen, K. J. Chou, H. C. Fang [et al.] // Nephron. - 2015. - Vol. 129 (3). - P. 189-196.

200. Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial / C. B. Bowling, P. W. Sanders, R. M. Allman [et al.] // Int. J. Cardiol. - 2013. - Jul. - Vol. 15, N 167 (1). - P. 151-156.

201. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis / F. L. Dini, S. Ghio, C. Klersy [et al.] // Int. J. Clin. Pract. - 2013. - Jul. - Vol. 67 (7). - P. 656-664.

202. Eligibility to treatment and economic effect of the implementation of the new US or European Society of Hypertension/European Society of Cardiology hypertension guidelines / P. Marques-Vidal, G. Waeber, B. Waeber, P. Vollenweider // J. Hypertens. - 2015. - Vol. 33 (4). - P. 868-873.

203. Epidemiology and outcome of the cardio-renal syndrome / D. N. Cruz, M. Gheorghiade, A. Palazzuoli [et al.] // Heart Fail. Rev. - 2011. - Nov. - Vol. 16 (6). - P. 531-542.

204. Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to renal resistances / M. Iacoviello, M. Leone, V. Antoncecchi, M. M. Ciccone // World J. Clin. Cases. - 2015. - Vol. 3 (1). - P. 10-19.

205. Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study / M. Legrand, B. De Berardinis, H. K. Gaggin // PLoS One. - 2014.- Nov. - Vol. 11, N 9 (11). - e112313.

206. Functional and circulatory renal changes in advanced heart failure / E. Demesova, E. Goncalvesova, P. Slezak, P. Pontuch // Bratisl. Lek. Listy. - 2015. - Vol. 116 (2). - P. 83-87.

207. Global and regional burden of disease and risk factors, 2001 : systematic analysis of population health data / A. D. Lopez , C. D. Mathers, M. Ezzati [et al.] // Lancet. - 2006. - Vol. 367, N 3524. - P. 1747-1757.

208. Glomerular filtration and functional renal reserve in nephrologically healthy workers of the Kovel's railway / A. V. Kravchuk, O. O. Zhizhnevskaya, L. V. Romanov, E. A. Gozhenko // Актуальные проблемы транспортной медицины. - 2013. - № 1 (31). - С. 90-97.

209. Gozhenko A. I. Clinical pathophysiology of proteinuria / A. I. Gozhenko, A. V. Khaminich // Загальна патологія та патологічна фізіологія. - 2010. - Т. 5, № 3. - С. 9-16.

210. Grover A. An overview of chronic disease models: a systematic literature review / A. Grover, A. Joshi // Global Journal of Health Sciences. - 2015. - Vol. 7, N 2. - P. 210-226.

211. Health for All Database [Електронний ресурс]. - Режим доступу : http://data.euro.who.int/hfadb/

212. High-NaCl diet impairs dynamic renal blood flow autoregulation in rats with adenine-induced chronic renal failure / A. Saeed, G. F. DiBona, E. Grimberg [et al.] // Am. J. Physiol. Regul. Integr. Comp. Physiol. - 2014. - Vol. 306 (6). - P. 411-419.

213. Hospital-based and telemonitoring guided home-based training programs: Effects on exercise tolerance and quality of life in patients with heart failure (NYHA class III) and cardiac resynchronization therapy. Arandomized, prospective observation / E. Smolis-B№k, R. D№browski, E. Piotrowicz [et al.] // Int. J. Cardiol. - 2015. - Vol. 199. - P. 442-447.

214. Hunter R. W. Glucocorticoids and renal Na+ transport: implications for hypertension and salt sensitivity / R. W. Hunter, J. R. Ivy, M. A. Bailey // J. Physiol. - 2014. - Vol. 592, Pt 8. - P. 1731-1744.

215. Hyponatremia in critically ill patients / R. Padhi, B. N. Panda, S. Jagati, S. C. Patra // Indian J. Crit. Care Med. - 2014. - Vol. 18 (2). - P. 83-87.

216. Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome / V. Tasdemir, A. K. Oguz, I. Sayin, I. Ergun // Int. Urol. Nephrol. - 2015. - Vol. 4. - P. 23-26.

217. Incretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart disease / R. A. Sanchez, H. Sanabria, C. de Los Santos, A. J. Ramirez // World J. Diabetes. - 2015. - Vol. 6 (11). - P. 1186-1197.

218. Index Mundi [Електронний ресурс]. - Режим доступу : http://www.indexmundi.com/

219. Kopp U. C. Role of renal sensory nerves in physiological and pathophysiological conditions / U. C. Kopp // Am. J. Physiol. Regul. Integr. Comp. Physiol. - 2015. - Jan. - Vol. 15, N 308 (2). - P. 79-95.

220. Kovalevska L. A. Renal dysfunction and anemia features in geriatric patients with chronic heart failure / L. A. Kovalevska // China Journal of Modern Medicine. - 2013. - Vol. 4. - P. 13-18.

221. Ledoux P. Cardiorenal syndrome / P. Ledoux // Avenir Med. - 1951. - Vol. 48 (8). - P. 149-153.

222. Luft F. C. Clinical salt deficits / F. C. Luft // Pflugers Arch. - 2015. - Vol. 467 (3). - P. 559-563.

223. Mallamaci F. Salt and the heart in chronic kidney disease: an atrial connection / F. Mallamaci, G. Tripepi // Nephrol. Dial. Transplant. - 2013. - Vol. 28 (9). - P. 2210-2211.

224. Mann D. L. Innate immunity and the failing heart: the cytokine hypothesis revisited / D. L. Mann // Circ. Res. - 2015. - Vol. 116 (7). - P. 1254-1268.

225. McNeice A. H. Advances in clinical cardiology / A. H. McNeice, N. M. McAleavey, I. B. Menown // Adv. Ther. - 2014. - Vol. 31 (8). - P. 837-860.

226. Mechanisms of renal hyporesponsiveness to BNP in heart failure / E. E. Egom, T. Feridooni, A. Hotchkiss [et al.] // Can. J. Physiol .Pharmacol. - 2015. - Jun. - Vol. 93 (6). - P. 399-403.

227. Menzies R. I. Renal P2 receptors and hypertension / R. I. Menzies, R. J. Unwin, M. A. Bailey // Acta Physiol (Oxf). - 2015. - Jan. - Vol. 213 (1). - P. 232-241.

228. Nomogram for estimating glomerular filtration rate in elderly people / N. M. Fernandes, N. Fernandes, E. J. Magacho, M. G. Bastos // J. Bras. Nefrol. - 2015. - Sep. - Vol. 37 (3). - P. 379-381.

229. Novel Agents for the Prevention and Management of Hyperkalemia / P. A. McCullough, M. R. Costanzo, M. Silver [et al.] // Rev. Cardiovasc. Med. - 2015. - Vol. 16 (2). - P. 140-155.

230. N-terminal pro B-type natriuretic peptide, STAT [Електронний ресурс]. - Режим доступу: https://usdiagnostics.roche.com/products/ 05390109160/PARAM1200/overlay.html

231. NTNDR 27 [Електронний ресурс]. - Режим доступу : http://www.fda.gov

232. Onuigbo M. A. RAAS Inhibition and Cardiorenal Syndrome / M. A. Onuigbo // Curr. Hypertens. Rev. - 2014. - Vol. 10 (2). - P. 107-111.

233. Oral sodium and potassium binders in heart failure / A. A. Morris, R. T. Cole, J. Butler, D. Gupta // Curr. Heart Fail Rep. - 2015. - Apr. - Vol. 12 (2). - P. 107-111.

234. Pathogenesis of arrhythmias in a model of CKD / C. H. Hsueh, N. X. Chen, S. F. Lin [et al.] // J. Am. Soc. Nephrol. - 2014. - Dec. - Vol. 25 (12). - P. 2812-2821.

235. Pathophysiology of cardiorenal syndrome in decompensated heart failure: role of lung-right heart-kidney interaction / M. Guazzi, P. Gatto, G. Giusti [et al.] // Int. J. Cardiol. - 2013. - Nov. - Vol. 30, N 169 (6). - P. 379-384.

236. Pentoxifylline in heart failure: a meta-analysis of clinical trials / S. Champion, N. Lapidus, G. Cheriй [et al.] // Cardiovasc. Ther. - 2014. - Vol. 32 (4). - P. 159-162.

237. Physical and functional links between anion exchanger-1 and sodium pump / Y. Su, R. S. Al-Lamki, K. G. Blake-Palmer // J. Am. Soc. Nephrol. - 2015. - Feb. - Vol. 26 (2). - P. 400-409.

238. Pollock E. The cardiorenal problem / E. Pollock, A. Nowak // Swiss Med Wkly. - 2014. - Vol. 144. - w14051.

239. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction / J. Casado Cerrada, F. J. Carrasco Sбnchez, J. I. Pйrez-Calvo [et al.] // Int. J. of Clin. Practice. - 2015. - Aug. - Vol. 69 (8). - P. 829-839.

240. Qavi A. H. Clinical Use of Diuretics in Heart Failure,Cirrhosis, and Nephrotic Syndrome / A. H. Qavi, R. Kamal, R. W. Schrier // Int. J. Nephrol. - 2015. - Vol. 2015. - 975934.

241. Reference laboratory values for digoxin following publication of Digitalis Investigation Group (DIG) trial data / P. J. Hauptman, P. McCann, J. M. Romero, M. Mayo // JAMA Intern. Med. - 2013. - Vol. 173 (16). - P. 1552-1554.

242. Regulatory roles of nitric oxide and angiotensin II on renal tubular transport / S. Horita, M. Nakamura, A. Shirai [et al.] // World. J. Nephrol. - 2014. - Vol. 3 (4). - P. 295-301.

243. Renal nerve stimulation leads to the activation of the Na+/H+ exchanger isoform 3 via angiotensin II type I receptor / R. B. Pontes, R. O. Crajoinas, E. E. Nishi [et al.] // Am. J. Physiol. Renal. Physiol. - 2015. - Vol. 308 (8). - P. 848-856.

244. Renal neurohormonal regulation in heart failure decompensation / S. Jцnsson, M. B. Agic, F. Narfstrцm [et al.] // Am. J. Physiol. Regul. Integr. Comp. Physiol. - 2014. - Vol. 307 (5). - P. 493-497.

245. Risk prediction in patients with heart failure: a systematic review and analysis / K. Rahimi, D. Bennett, N. Conrad [et al.] // JACC Heart Fail. - 2014. - Vol. 2 (5). - P. 440-446.

246. Roger V. L. Epidemiology of heart failure / V. L. Roger // Circ Res. - 2013. - Vol. 113 (6). - P. 646-659.

247. Role of salt receptor cavity in shaping physiological reactions of water-salt homeostasis / A. i. Gozhenko, M. s. Zhigalina-Gritsenyuk, W. Zukow // Journal of Health Sciences. - 2013. - Vol. 3, N 1 (11). - P. 16-27.

248. Ronco C. Cardiorenal syndrome / C. Ronco, L. Di Lullo // Heart Fail Clin. - 2014. - Vol. 10 (2). - P. 251-280.

249. Saepudin S. Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure / S. Saepudin, P. A. Ball, H. Morrissey // BMC Cardiovasc. Disord. - 2015. - Vol. 15. - P. 88.

250. Santos-Araъjo C. Clinical value of natriuretic peptides in chronic kidney disease / C. Santos-Araъjo, A. Leite-Moreira, M. Pestana // Nefrologia. - 2015. - Vol. 35 (3). - P. 227-233.

251. Serum sodium levels and patient outcomes in an ambulatory clinic-based chronic kidney disease cohort / S. W. Han, A. Tilea, B. W. Gillespie [et al.] // Am. J. Nephrol. - 2015. - Vol. 41 (3). - P. 200-209.

252. Shah K. S. Novel biomarkers in heart failure with preserved ejection fraction / K. S. Shah, A. S. Maisel // Heart Fail Clin. - 2014. - Vol. 10 (3). - P. 471-479.

253. Silverberg D. The cardio-renal anaemia syndrome: does it exist? / D. Silverberg, D. Wexler, M. Blum // Nephrol. Dial. Transplant. - 2003. - Vol. 18 (8). - P. 7-12.

254. Sodium excretion and risk of developing coronary heart disease / M. M. Joosten, R. T. Gansevoort, K. J. Mukamal [et al.] // Circulation. - 2014. - Vol. 129 (10). - P. 1121-1128.

255. Song W. Atrial natriuretic peptide in cardiovascular biology and disease / W. Song, H. Wang, Q. Wu // Gene. - 2015 - Vol. 569 (1). - P. 1-6.

256. STATISTICA 10.0 [Електронний ресурс]. - Режим доступу : http://www.statsoft.com

257. Tamargo J. Comparison of agents that affect aldosterone action / J. Tamargo, A. Solini, L. M. Ruilope // Semin. Nephrol. - 2014. - Vol. 34 (3). - P. 285-306.

258. Tamargo J. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents / J. Tamargo, J. Segura, L. M. Ruilope // Expert Opin Pharmacother. - 2014. - Vol. 15 (5). - P. 605-621.

259. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT) / W. T. Ambrosius, K. M. Sink, C. G. Foy [et al.] // Clin. Trials. - 2014. - Vol. 11 (5). - P. 532-546.

260. The effect of continuous blood purification on the prognosis of cardiorenal syndrome patients / F. Jia, P. Rong, D. Li [et al.] // Cell Biochem. Biophys. - 2015. - Vol. 71 (2). - P. 957-961.

261. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial / I. de Brito-Ashurst, L. Perry, T. A. Sanders [et al.] // Heart. - 2013. - Vol. 99 (17). - P. 1256-1260.

262. Treating essential hypertension. The first choice is usually a thiazide diuretic // Prescrire Int. - 2014. - Vol. 23 (152). - P. 215-220.

263. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension / C. Rosendorff, D. T. Lackland, M. Allison [et al.] // Circulation. - 2015. - Vol. 131 (19). - P. 435-470.

264. Tsuruya K. Cardiorenal syndrome in chronic kidney disease / K. Tsuruya, M. Eriguchi // Curr. Opin. Nephrol. Hypertens. - 2015. - Vol. 24 (2). - P. 154-162.

265. Ultrafiltration in decompensated heart failure with cardiorenal syndrome / B. A. Bart, S. R. Goldsmith, K. L. Lee [et al.] // N. Engl. J. Med. - 2012. - Vol. 367 (24). - P. 2296-2304.

266. Update in cardiology: vascular risk and cardiac rehabilitation / E. Galve, A. Cordero, V. Bertomeu-Martнnez [et al.] // Rev. Esp. Cardiol. (Engl. Ed). - 2015. - Vol. 68 (2). - P. 136-143.

267. Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome / K. Chaudhary, K. Malhotra, J. Sowers, A. Aroor // Cardiorenal. Med. - 2013. - Vol. 3 (3). - P. 208-220.

268. Vargas-Uricoechea H. Effects of thyroid hormones on the heart / H. Vargas-Uricoechea, A. Bonelo-Perdomo, C. H. Sierra-Torres // Clin. Investig. Arterioscler. - 2014. - Vol. 26 (6). - P. 296-309.

269. Verbrugge F. H. Management of the cardiorenal syndrome in decompensated heart failure / F. H. Verbrugge, L. Grieten, W. Mullens // Cardiorenal. Med. - 2014. - Vol. 4 (3-4). - P. 176-188.

270. Water and sodium in heart failure: a spotlight on congestion / G. Parrinello, S. J. Greene, D. Torres [et al.] // Heart Fail. Rev. - 2015. - Vol. 20 (1). - P. 13-24.

271. Wang J. Health-related quality of life in hypertensive patients / J. Wang, D. Kang, Q. Hong // Zhonghua Yi Xue Za Zhi. - 1999. - Vol. 79 (8). - P. 599-602.

Размещено на Allbest.ru

...

Подобные документы

Работы в архивах красиво оформлены согласно требованиям ВУЗов и содержат рисунки, диаграммы, формулы и т.д.
PPT, PPTX и PDF-файлы представлены только в архивах.
Рекомендуем скачать работу.